AbCellera to Present at Upcoming Investor Conferences in September
AbCellera Reports Q2 2024 Business Results
AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
AbCellera to Collaborate with Biogen